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Abstract 
 
Minor fibrillar collagen types V and XI, are those less abundant than the fibrillar collagens 
types I, II and III. The alpha chains share a high degree of similarity with respect to protein 
sequence in all domains except the variable region. Genomic variation and, in some cases, 
extensive alternative splicing contribute to the unique sequence characteristics of the 
variable region. While unique expression patterns in tissues exist, the functions and 
biological relevance of the variable regions have not been elucidated. In this review, we 
summarize the existing knowledge about expression patterns and biological functions of 
the collagen types V and XI alpha chains.  Analysis of biochemical similarities among the 
peptides encoded by each exon of the variable region suggest the potential for shared 
function. The alternative splicing, conservation of biochemical characteristics in light of 
low sequence conservation, and evidence for intrinsic disorder, suggests modulation of 
binding events between the surface of collagen fibrils and surrounding extracellular 
molecules as a shared function. 
 
Keywords: minor fibrillar collagens; variable regions; alternative splicing; fibrillogenesis; heparan sulfate 
binding sites; intrinsic disorder; tyrosine sulfation. 
 
Introduction 
 
Collagens are the predominant proteins of the extracellular matrix in animals. They play diverse roles in cell 
behavior, cell adhesion, differentiation, cell migration, and in tissue repair. To date, there are 29 different 
collagens (Kadler et al.,2007; Soderhall et al., 2007), each of which is composed of three polypeptide alpha 
chains forming either heterotrimers or homotrimers.  Depending on their functions and domain homology, 
collagens can be grouped into fibril-forming, fibril associated collagens with interrupted triple helices (FACITs), 
network forming, beaded-filament-forming, anchoring, or transmembrane collagens (Kadler et al.,2007). 
Collagen types I, II, III, V and XI as well as the recently discovered XXIV and XXVII, are fibril-forming 
collagens. Historically, the fibrillar collagens are further divided into major (I, II and III) and minor (V and XI) 
fibrillar collagens based on their abundance in the collagen fibrils. 
 
The importance of collagens has been shown by their profound influence in connective tissue formation and 
function. For example, mutations in collagen type V genes can cause Ehlers-Danlos syndrome with joint 
hypermobility (Schwarze et al.,2000; Wenstrup et al., 2000; Michalickova et al., 1998; Richards et al., 1998), 
whereas mutations in collagen type XI genes can cause Marshall and Stickler syndromes, each resulting in 
altered facial appearance, eye abnormalities, joint alterations, and hearing loss (Sirko-Osadsa et al., 1998; 
Pihlajamaa et al., 1998; Annunen et al., 1999; McGuirt et al., 1999; Melkoniemi et al.,2000).  Mutations in 
Col11a1 have recently been shown to give rise to fibrochondrogenesis, a severe autosomal-recessive, short-
limbed skeletal dysplasia (Tompson et al. 2010).  Three different collagen type V alpha chains have been 
described in humans: Col5a1, Col5a2 and Col5a3. Similarly, in collagen type XI, there are three alpha chains, 
Col11a1, Col11a2 and Col11a3. However, Col11a3 is actually Col2a1 (alpha1 chain, type II), one of the major 
fibril-forming collagens. Minor fibril-forming collagens are composed of several domains, including the C-
propeptide (NC1), a major helix (COL1) and minor helix (COL2) separated by a short sequence (NC2), and the 
N-terminal domain (NC3). The NC1 domain is well conserved among fibril-forming collagens, whereas the 
NC3 domain varies in size, primary structure, and subdomain compositions (Ricard-Blum and Ruggiero, 2005). 
In the minor fibrillar collagens, NC3 contains either a cysteine-rich repeat domain (CRR)/ von Willebrand factor 
type C domain, characterized by the presence of 10 cysteines (Col5a2 and Col11a3), or a thrombospondin N-
terminal-like (TSPN) domain adjacent to a variable region (VR) (Col5a1, Col5a3, Col11a1 and Col11a2). 
Despite the differences in NC3 domains, Col5a2 shares similar expression patterns with other minor fibrillar 
collagen alpha chains with which it associates. At early development stages, minor fibrillar collagens are 
expressed in a variety of different tissues; whereas at later development stages, more restricted skeleton related 
expression patterns are observed (Andrikopoulos, et al., 1992; Oxford et al., 1995; Yoshioka et al., 1995; 
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 Tsumaki. and Kimura, 1995; Lui et al., 1996; Roulet et al., 2007; Sugimoto et al., 1998; Imamura et al., 2000). 
Both Col24a1 and Col27a1, exhibit TSPN and VR domains common to collagen type V and XI; however, they 
differ from the other minor fibrillar collagen alpha chains with respect to interruptions within the major helical 
region (Ricard-Blum and Ruggiero, 2005).  
 
Type V and XI collagens form heterotypic collagen fibrils by cooperating with type I and type II collagens, 
respectively (Ricard-Blum and Ruggiero, 2005, Fernandes et al., 2007).  Additional complexity arises due to the 
fact that the alpha chains of collagens type V and XI can also form heterotrimers with each other in a tissue 
dependent manner (Fichard et al., 1995). Therefore, it has been proposed that type V and type XI collagens are 
not actually distinct collagens, but rather belong to the same family, collagen type V/XI (Fichard et al., 1995). 
In agreement with this and the structural differences among fibrillar collagens, the alpha chains of fibrillar 
collagens are classified into three distinct subclasses, in which Col5a1, Col5a3, Col11a1 and Col11a2 belong to 
the same clade (Zhang et al., 2007). In this review, we focus on the minor fibril-forming collagens with specific 
emphasis on the variable regions of Col5a1, Col5a3, Col11a1, and Col11a2.  
 
Alternative splicing in the VR.  Alternative splicing (AS) is a commonly utilized pathway for higher 
organisms to enrich the functional proteome without increasing the number of genes (Romero et al., 2006; 
Stamm et al., 2005; Ben-Dov et al., 2008).. It is a process mediated by the spliceosome composed of 
ribonucleoproteins (RNPs) (Wahl et al., 2009). Recent studies indicate that genes undergoing AS often function 
in cell differentiation and development. The outcomes of AS are either the addition/deletion of a new protein 
domain or the introduction of a stop codon. Consequently, this would lead to a potential change in the function 
of the protein (Stamm et al., 2005).  Historically, the VR of the collagen molecule is defined as a region of low 
homology among different collagen alpha chains. Collagen type XI alpha chain genes exhibit extensive AS in 
the VR in human, rat (Oxford et al., 1995; Tsumaki. and Kimura, 1995; Lui et al., 1996) and other characterized 
species, indicating a possible role in cell differentiation and development. Although no evidence exists for AS in 
the genes encoding collagen type V alpha chains in any species reported, preliminary data from our laboratory 
indicates that AS does take place within the paralogs of zebrafish type V alpha chains. The alternatively spliced 
variable regions are located from exon6 to exon8 for both Col11a1 and Col11a2 (Oxford et al., 1995; Tsumaki. 
and Kimura, 1995; Lui et al., 1996). In Col11a1, there are two different forms of exon6, referred to as exon6A 
and exon6B, which encode amino acids with distinct negative and positive charge under physiological 
conditions, respectively (Oxford et al., 1995). Although different combinations of exons in the variable regions 
of Col11a1 and Col11a2 could theoretically result in many splicing-forms, the most abundant detected so far in 
Col11a1 are the combinations exon6A-7-8, exon6B-7, and exon7 alone (Oxford et al., 1995; Morris et al., 2000); 
in the case of Col11a2, the combinations exon6, exon7 and exon8 can be either included or excluded (Tsumaki. 
and Kimura, 1995; Lui et al., 1996). The most abundantly detected form of Col11a2 results from the exclusion 
of exons 6, 7, and 8 at all times other than early development.  Sequence comparison between human, chimp, 
mouse, rat, chicken, and zebrafish shows some conserved sequence for all of the exons encoding the variable 
region in Col5a1, Col5a3, Col11a1 and Col11a2 (Figure 1). However, the degree of conservation is relatively 
low in comparison to other regions of the same proteins.  Supplemental Figure 1 shows sequence alignment; and 
accession numbers are indicated in Supplemental Table 1. 
 
Isoform-dependent expression patterns. Much attention has been focused on the temporal and spatial 
expression patterns for minor fibrillar collagens (Table 1).  In early developmental stages of the mouse embryo, 
Col5a1 expression is observed in the aorta, heart, branchial arches, developing mesenchyme and 
neuroepithelium; late in development, its expression is limited to bones, vertebral column, cornea, tendons and 
ligaments (Roulet et al., 2007; Imamura et al., 2000). For Col5a2, early expression is found in the peritoneal 
membranes, intestinal and craniofacial mesenchyme.  At later stages, the expression is restricted to some 
ossification centers, joints, tendons, the atrioventricular valve of the heart, and head structures including 
mandibular arch, optic nerve region, otic capsule, and calvarial mesenchyme (Andrikopoulos et al., 1995). 
Additionally, the expression of Col5a2 has also been reported in the bovine vitreous (Mayne et al., 1993). The 
expression of Col5a3 has been shown as a subset of that of Col5a1 (Imamura et al., 2000).  The expression of 
Col11a1 tends to be broader than that of the collagen type V genes discussed above. Col11a1 has been detected 
in limbs, vertebrae, mandibular bones, otic vesicle, the atrioventricular valve of the heart, neuroepithelium of the 
brain, liver, kidney, lung, muscle and intestine (Oxford et al., 1995; Yoshioka et al., 1995; Liu et al., 1995).  
Additional expression sites for Col11a1 include the mesothelial layer of the cornea, and perioptic mesenchyme 
within the sclera. Compared to the expression of Col11a1, Col11a2 has a more restricted, cartilage-related 
expression pattern in developing limbs and the axial skeleton (Sugimoto et al., 1998). Common localization 
patterns of the alpha chains of collagen type V and XI in mesenchymal tissues at the early development stages 
indicates the possibility for the formation of hybrid V/XI triple helical molecules. 
 
2
 As a result of AS, Col11a1 and Col11a2 have several different isoforms that demonstrate differential expression 
patterns within the expression sites of total Col11a1 and Col11a2. For Col11a1, the predominantly expressed 
isoforms in non-cartilaginous tissues including brain, muscle, calvaria, heart, kidney, liver and lung, are 
exon6A-7-8 and exon7-8. In contrast, in cartilaginous tissues, the expression patterns are more complicated 
(Oxford et al., 1995). The localization of Col11a1 isoforms in cartilage-derived tissues was investigated in the 
rat humerus, where exon6B-7 was found to be restricted to the periphery of the cartilage covering the 
perichondrium of the diaphysis, and the expression of exon7-8 was prevalent in prechondrogenic mesenchyme 
and immature cartilage (Morris et al., 2000). Moreover, the expression of exon7-8 diminished as chondrocytes 
underwent hypertrophy, indicating a potential association with chondrocyte maturation.  In the case of Col11a2, 
the expression of the isoform containing exons 6-8 is detected in non-chondrogenic tissues, including muscle, 
brain, heart, eye, periosteum, calvarial mesenchymal layer, but not in cartilaginous tissues (Lui et al., 1996; 
Sugimoto et al., 1998). Although Col11a1 and Col11a2 have different expression patterns, some cartilaginous 
tissues are enriched for variable region domains lacking amino acids bearing a negative charge at physiological 
pH. In the case of the cartilage that is immediately adjacent to the perichondrium at locations of mineralization, 
the variable region is comprised of amino acids bearing a positive charge at physiological pH within the NC3 
domain, as seen in the amino acid sequence encoded by exon 6B of Col11a1. Exons6-7-8 of Col11a2 encode 
acidic sequences which are omitted from Col11a2 in cartilage.  
 
Functions of the minor fibrillar collagens.  Although the function of the minor fibrillar collagens are not fully 
understood, targeted mutations provide some insight.  The first targeted minor fibrillar collagen was mouse 
Col5a2. The heterozygous mutant (exon 6 deletion) has an apparently normal phenotype, whereas the 
homozygous mutants feature spinal lordosis and kyphosis with a marginal survival rate (Andrikopoulos et al., 
1995). The primary cause of death in the homozygous mutants is thought to be the effects of respiratory 
problems caused by spinal abnormalities, which result from the loss of tensile strength in the ligaments. 
Additionally, mutants also exhibit skin fragility and collapse of the corneal stroma caused by abnormal 
assembly of type I collagen fibrils (Andrikopoulos et al., 1995). 
 
A truncated form of Col5a1 was used to demonstrate that alteration in Col5a1 leads to modification of the fibril 
morphology synthesized by chicken corneal fibroblasts (Marchant et al., 1996). Deletion of exons 3 and 4 of 
Col5a1 in mice is associated with embryonic lethality and a lack of mesenchymal collagen fibrils (Wenstrup et 
al., 2004). Together, these studies further support the theory that type V collagen chains are critical in the 
regulation of fibrillogenesis (Birk 2001). However, in vitro studies showed that a heterotrimer of collagen V is 
able to regulate the diameter of collagen I fibrils but not the heterotrimer, indicating that the regulation of the 
fibril diameter by collagen V occurs in a stoichiometric-dependent manner (Chanut-Delalande et al., 2001). Also, 
collagen V can form heterotrimers with collagen XI depending on the tissue content (Fichard et al., 1995). 
Therefore, the role of minor fibrillar collagens in fibril assembly may rely on the specific collagen alpha chains 
expressed in a given tissue. 
 
The cho/cho mouse is a homozygous mutant of Col11a1 (Li et al.. 1995).  These mice display autosomal 
recessive chondrodysplasia, and die at birth with wide range cartilage abnormalities. The phenotype is cause by 
a reading frame shift at +570 nucleotides resulting in a premature stop codon downstream from the deletion (Li 
et al., 1995).  Although the phenotype of this mutant has been well documented (Li et al., 1995), the mechanism 
is not yet clear. Similar to type V collagen, one of the roles for Col11a1 is that it may be able to regulate the 
diameter of collagen fibrils.  This is supported by evidence that thickened, shorter collagen fibrils have been 
observed in the cho/cho mouse (Fernandes et al., 2007; Li et al., 1995). Additionally, in vitro studies show that 
collagen XI is crucial for normal collagen type II fibril assembly (Blaschke et al., 2000). A model has been 
proposed in which the NC3 domain of Col11a1 acts as the regulator for the uniformity of thin collagen fibrils in 
developing cartilage (Fernandes et al., 1995; Gregory et al., 2000).  A “10+4” model has been described for thin 
collagen fibrils containing collagen type II, IX and XI where collagen type XI is found within the core of four 
microfibrils surrounded by collagen type II.  Collagen type IX is found associated with the surface of the 
heterotypic fibril (Holmes and Kadler, 2006). The model shown in Figure 2 combines known details of the 
structure of the minor fibrillar collagen type XI within a heterotypic collagen fibril showing the NC3 domains 
on the surface of the fibril. 
 
The VR of minor fibrillar collagen alpha chains are predicted to be at the surface of the collagen fibril, thus 
contributing to the biochemical nature of the fibrillar surface.  In this location, the NC3 domain can contribute to 
regulation of fibrillar growth by a mechanism that relies upon steric hindrance and/or molecular interactions 
with other constituents of the extracellular matrix. Predicted surface properties and potential interactions are 
enabled by the minor fibrillar collagen constituents at the surface of a collagen fibril (Zhu et al., 1999; Xu et al., 
2005; Leitinger and Hohenester, 2007; Kadler et al., 2008). Worthy of mention, the expression of Col11a1 has 
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 also been detected in certain type of cancers (Fischer et al., 2001; Halsted et al., 2008), indicating a possible role 
for Col11a1 in carcinogenesis and metastasis.  
 
A similar approach has been used to study the function of Col11a2, producing a mutant (deletion of exons 27-28; 
premature stop codon in the insertion) resulting in a milder phenotype compared to the cho/cho mouse. However, 
the mutant does exhibit some phenotypic traits of nonocular Stickler syndrome and otospondylomegaepiphyseal 
dysplasia (OSMED) in humans, including deafness and a receding snout, with disorganized chondrocytes in the 
growth plates of long bones also observed (Li et al., 2001). 
 
Although different mutants produce diverse phenotypes, homozygous mutants of both Col5a1 and Col11a1 
show more severe abnormalities leading to neonatal or embryonic death compared to those of Col5a2 and 
Col11a2, suggesting the crucial roles of these two genes in early development. Dose-dependency is indicated by 
heterozygous mutants, shedding some light on the mechanism. Dermal fibroblasts from patients with Ehlers-
Danlos syndrome with haploinsufficiency of Col5a1 exhibit decreased Col1a1 fibrillar assembly in the 
extracellular matrix (Wenstrup et al., 2004). In mutants of Col5a2, the collagen composition of the cornea 
shows larger fibrillar diameter compared to wild type, exhibiting a dose-dependent relationship with respect to 
the genetic composition of Col5a2 (Andrikopoulos et al., 1995).  
 
The relationship of the cho/+ heterozygous mutant to the progression of osteoarthritis has also been explored 
and found to be caused by an increased interaction between Col2a1 and discoidin domain receptor 2 (DDR2) 
(Xu et al.,2005). DDR2 is a receptor tyrosine kinases (RTKs), functioning as a collagen receptor independent of 
β1 integrins (Leitinger and Hohenester, 2007). It is thought that low levels of Col11a1 cause an altered cartilage 
collagen fibril structure leading to over-exposure of Col2a1 to DDR2, which, in turn, up-regulates the 
expression of matrix metalloproteinase 13 (MMP-13) and hence, degeneration of cartilage that is associated 
with disease (Xu et al.,2005). This indicates that the functions of collagens may rely on the other molecules that 
interact with them, within the extracellular matrix and on the cell surface. A recent review summarized the 
collagen receptors, including integrin, DDR1 and DDR2, and Glycoprotein VI among others (Leitinger and 
Hohenester, 2007). 
 
To date, most observations of the effect of mutations have been made either at the time of death or after birth 
using mouse models. Limited information is currently available to address the potential roles that minor fibrillar 
collagens play during early embryonic development. Recently, transient expression of Col5a1 has been detected 
in mouse epidermal cells during early development (Roulet et al., 2007). Thus, careful re-examination of the 
minor fibrillar collagens is needed to understand the spatiotemporal expression patterns during early 
development, particularly in the established mutants. 
 
The alternatively spliced isoforms in collagen type XI genes have not been studied in vivo or in transgenic 
mutant studies. Varied, overlapping or perhaps opposing roles are suggested by studies in which isoforms 
generated by alternative splicing have been analyzed.  For example, FGF8 (fibroblast growth factor 8) produces 
two evolutionally conserved isoforms by alternative splicing: FGF8a and FGF8b. In Xenopus, FGF8b is a 
mesoderm inducer, whereas FGF8a is involved in posterior neural development (Fletcher et al., 2006). Another 
study in a mouse model system demonstrated a partial compensatory effect from FGF8a and FGF8b deficient 
embryos (Guo and Li, 2007), indicating overlapping functions of these two molecules. 
 
Based on in vitro studies, different splice-forms of Col11a1 have also been shown to influence the processing of 
Col11a1 itself. Acceleration of the processing of pro-α1(XI) by BMP-1 has been observed by the presence of 
either p6B (encoded by exon6B) or p8, compared to p7 and p6A (Medeck et al., 2003). Either retention of or 
release of N-terminal propeptides could affect the gradients of morphogens that bind to the NC3 domain. 
Because the NC3 domain of Col11a1 is slowly processed, the expression of exon6B and exon8 may be related 
to higher availability of certain molecules that bind to p6B or p8 in tissues where they are expressed. Studies of 
collagen type V show an influence on cell behavior. The N-terminal domain of Col5a4 has been found to 
modulate Schwann cell migration by utilizing syndecan-3 (Erdman et al., 2002), which is a transmembrane 
heparan sulfate proteoglycan. Although not specified as to which alpha chain or which domain is involved, 
Luparello and colleagues demonstrated that type V collagen can induce apoptosis in a cell line-dependent 
manner (Pucci-Minafra et al., 2000; Luparello and Sirchia, 2005). Heparan sulfate (HS) binding sites have also 
been identified in the NC3 domain of Col5a3 exhibiting specific adherence to osteosarcoma cells (Yamaguchi et 
al., 2005). Interestingly, a HS binding site has been described in the spliced region of Col11a1, encoded by 
exon6B, which is expressed in chondrocytes (Warner et al., 2006). Although exclusion of exon6B would 
naturally abolish this binding site as demonstrated in the isoform containing exon6A-7-8, its function is not clear. 
Collagen type XIV does not belong to the minor fibrillar collagens, however, its alternatively spliced F3 domain 
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 behaves similarly to exon6B in Col11a1. It has been showed that the F3 domain of Col14a1 has both heparin 
binding and cell binding properties (Imhoff and Trueb 2001). Thus, it is possible that the inclusion of exon6B in 
Col11a1 may have a similar function in cell surface association. 
 
Sequence similarity in the VRs.  Characterized with low homology among different alpha chains, the variable 
regions share patterns of amino acid residues in polypeptide chains among human, chimpanzee, mouse, rat, 
chicken and zebrafish. For Col5a1, a “YYYEYPYYED” is highly conserved among all the species compared. 
The peptide encoded by exon8 (p8) in Col5a1 has conserved “FTEETI” and “IGPGMPANQDT” fragments 
among different species. As for Col5a3, the exon-intron boundaries of the zebrafish sequence are not well 
defined based on the current available annotations. Therefore, the alignment for this molecule was done without 
separating the exons. With some exceptions for the zebrafish sequences, the “KGKGKKRGRKGKGRKKNK” 
and “TMGP” as well as “FRAAE” and “FQIFP” are conserved among species. Similarly, there are several 
different conserved segments among species in Col11a2: “DYEPPYY” is conserved in p6; while for p8, 
“EQTDLQ” and “YDYTYGYGD” as well as “DYREETELGPALSAET” are conserved among species. In the 
case of Col11a1, alignment and comparison of different species indicate that tyrosines (Y) and lysines (K) are 
highly conserved in the peptides encoded by exon6A and exon6B, respectively. Higher similarity has been 
observed for p8 in Col11a1, specifically for the sequence signatures “DGDLGEYDF”, “YEYKEYE” and 
“FGPGVPAETD” which align well among these species. The alignments of sequence corresponding to p6 in 
Col5a1, p6 and p8 in Col11a2 as well as p6A and p8 in Col11a1 are tyrosine-rich; while p6 in Col5a3 and p6B 
in Col11a1 are lysine-rich (Figure 1) demonstrating further similarities among the Collagen V/XI alpha chains. 
 
Biochemical properties. As demonstrated by sequence alignment, peptides in different minor fibrillar collagens 
have similar biochemical composition. Although high overall similarity is not exhibited, they do possess similar 
biochemical properties and amino acid composition. To demonstrate this, theoretical isoelectric points were 
calculated. As summarized in Table 2, all the conserved fragments from VRs are acidic and negatively charged 
under physiological conditions, except those encoded by exon 6 in Col5a3 and by exon 6B in Col11a1.  
Although there is no direct evidence describing the role of the variable regions, the overall biochemical 
properties described in part by the isoelectric point may contribute to the function. In the case of Col11a2, this 
acidic segment is excluded from cartilaginous tissues (Sugimoto et al., 1998), indicating potentially strong 
biological relevance for the regulated inclusion and exclusion of this domain. Similarly for Col11a1, exon6A is 
favored in various tissues, whereas exon6B is restricted to the cartilage underlying the perichondrium of the 
diaphysis (Morris et al., 2000).  In summary, we predict a functional role dictated by the acidic and basic 
isoforms of the minor fibrillar collagens. 
 
Isoform-dependent post-translation modification.  Sulfation is one of the most prevalent modifications of 
extracellular molecules, playing a role in protein-protein interactions,
 
and enhancing the affinity of the binding 
partners (Bowman and Bertozzi, 1999).  Receptor-ligand interactions for a number of signaling molecules and 
their receptors are favored through tyrosine sulfation (Leyte et al., 1991; Huang et al., 1989; Seibert et al., 2002). 
Extracellular matrix molecules that undergo tyrosine sulfation include fibromodulin, osteoadherin, lumican, 
Ucma (Onnerfjord et al., 2004; Surmann-Schmitt et al., 2008), and fibronectin (Paul and Hynes, 1984; Liu and 
Lipman, 1985).  As shown by alignment, Col5a1, Col11a1 and Col11a2 are rich in tyrosines within the variable 
regions. Using SulfoSite (Chang et al., 2009) to predict the possible sulfation modifications, most of the tyrosine 
residues are predicted to undergo sulfation, although the probability varies from residue to residue (Figure 3). 
Experimental evidence exists for tyrosine sulfation in the case of the NC3 domain of Col5a1, by Fessler and 
colleagues (Fessler et al., 1986). In Col11a1, it was demonstrated that the splice variant containing exon6A-7-8 
is more widely expressed in tissues including non-cartilaginous ones (Chen et al., 2001).  Tyrosine sulfation 
may therefore play an important role in the function of Col11a1 in non-cartilaginous tissues.  
 
Intrinsic disorder.  Although cumulative evidence supports the idea that the different splice-forms have 
different functions on a time- or tissue-dependent manner (Stamm et al., 2005; Ben-Dov et al., 2008), the 
connection between AS and the functional changes that result remain to be addressed. A recent study attempted 
to connect the alternative splicing with intrinsic disorder (Romero et al., 2006), which may be important in 
modulating the conformation of polypeptide segments in proteins. To examine whether the minor fibrillar 
collagens have intrinsic disorder, particularly in the variable regions, we analyzed the human Col11a1, Col11a2, 
Col5a1 and Col5a3 by using VLXT PONDR (Figure 3) (Romero et al., 2001).  Not surprisingly, the major triple 
helices of all of the collagens analyzed were predicted to possess intrinsic disorder, since these regions are rich 
in G-X-Y repeats and match the criteria for intrinsic disorder. Interestingly, the variable regions were also found 
to have intrinsic disorder, indicating the potential for a functional role for this region in minor fibrillar collagens. 
Moreover, as discussed in previous sections, the variable region projects away from the triple helix in collagen 
fibrils. Together, it is possible that extracellular molecules interact with the VR thus inducing a conformational 
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 change, regulating the diameter of the collagen fibrils, or alternatively, providing a mechanism for molecular 
interactions. Whether the interaction of HS with this region functions in this way or not has yet to be established.  
 
Regulation of transcription and AS.  While the spatiotemporal expressions of different isoforms of type XI 
collagens, especially Col11a1, have been documented in different organisms, the mechanism determining 
specific expression patterns is still elusive. Studies of promoters of these collagen genes reveal that the common 
feature is a lack of a TATA box and an enrichment in GC content, except for Col5a2 (Table 3) (Fichard et al., 
1995; Lee and Greenspan, 1995; Yoshioka et al. 1995; Tsumaki et al., 1996; Kinoshita et al., 1997; Tsumaki et 
al., 1998; Penkov et al., 2000; Tanaka et al., 2002; Matsui et al., 2003; Matsuo et al., 2003; Nagato et al., 2004; 
Sakata-Takatani et al., 2004). The transcription factors identified for collagen type V and XI are quite similar, 
such as SP1 and CBF/NF (Table 3). Although CBF/NF has been recognized as a ubiquitous nuclear factor (Li et 
al., 1992), it may be involved in modulating the expression of Col1a2 in mesenchymal-origin tissues (Tanaka et 
al., 2004), indicating the complexity of the regulation of collagen genes. While co-expressed with collagen type 
XI chains, collagen type II is regulated by Sox9, which is a high mobility group (HMG) domain transcription 
factor (Bi et al., 1999). Similar to the Col2a1 chondrocyte-specific enhancer, two HMG protein binding 
consensus sites have been identified in Col11a2 (Bridgewater et al., 1998). Another study proved that these 
consensus sites of Col11a2 are indeed recognized by Sox9 (Bi et al., 1999). Currently, there is no direct 
evidence that Sox9 regulates the expression of Col11a1. However, seven conserved Sox pair sequences in the 
promoter of Col11a1 from both human and mouse have been identified by computational analysis (Davies et al., 
2007). Additionally, Lincoln and colleagues have shown that Sox9 as well as Col5a1 and Col11a1 are required 
for heart valve development (Lincoln et al., 2006; Lincoln et al., 2007). Therefore, it is possible that Sox9 
regulates the expression of Col11a1 and Col5a1. Most recently, the transactivation of Col11a1 by Lef1 was 
reported (Kahler et al., 2008); however the mechanistic details of regulation still remain to be investigated. 
Further, the responsible trans-acting factors that modulate alternative splicing in Col11a1 and Col11a2 are not 
currently known. Therefore, it is highly likely that other cis-acting elements and nuclear factors that specifically 
regulate the finely controlled expression of minor fibrillar collagen molecules remain to be discovered.  
 
Alternative splicing involves the recognition of the basic splicing elements, including 5’ donor site, 3’ acceptor 
site and the auxiliary cis-elements: exonic/intronic splicing enhancer (ESE/ISE) as well as silencer (ESS/ISS) by 
the spliceosome (Ladd and Cooper, 2002; Matlin et al., 2005). To analyze the splice exon-intron junction 
sequences in the variable region of minor fibrillar collagens, 20 nucleotides (nts) from both 5’ donor site and 3’ 
acceptor site were aligned among 4 different species (Supplementary Figure 2 and Supplementary Table 2). As 
is true for many alternatively spliced exons genome-wide, exons within the variable region of Col5a1, Col5a3, 
Col11a1 and Col11a2 have exon-intron sequences that are not consistent with the classic 5’ donor site 
(AGguragu) and 3’ acceptor site (yyyyyyynagG). The constitutively expressed exons display non-consensus 
junction sites in Col5a1 and Col5a3. Interestingly, the acceptor sites of intron 6A-6B and intron 6-7 in Col11a1 
and Col11a2, respectively, exhibit a potential hairpin structure (Supplementary Figure 2). Because of the 
inconsistency of the donor and acceptor sites in the variable region of minor fibrillar collagens, the other 
splicing elements, such as ESE/ISS as well as ISE/ISS, may play roles in regulating the alternatively spliced 
Col11a1 and Col11a2.  Recently, the importance of auxiliary cis-elements has been recognized in the 
determination of exon splicing patterns (Matlin et al., 2005). In Col2a1, exon2 is alternative spliced; the 
inclusion or exclusion of exon2 is regulated by the combination of a 5’ weak donor site and a stem-loop 
structure in the intron2 (McAlinden et al., 2005). Another study has shown that TIA-1 (T-cell-restricted 
intracellular antigen-1) can interact with the conserved stem-loop structure to regulate the alternative splicing 
(McAlinden et al., 2007). Exon7 of Col11a1 possesses a cis-acting function in the modulation of the alternative 
splicing (Chen et al., 2001).  Tsumaki and colleagues found that both the deletion of an upstream 290bp in the 
proximal promoter and the intron 1 sequence of Col11a2 could affect tissue expression pattern (Tsumaki et al., 
1996). Additional studies suggested that there are at least three different cis-acting elements involved in the 
modulation of the tissue-specific expression patterns of Col11a2 (Tsumaki et al., 1998).  Similar to collagen 
type XI, fibronectin is also found in cell type- and developmental stage-specific splice-forms derived by 
alternative splicing (Pankov and Yamada, 2002). Recent studies show that integrin-mediated signaling can 
modulate the pre-mRNA splicing of fibronectin through a non-stress c-Jun N-terminal kinase (JNK) signaling 
pathway (Pelish et al., 2005). Interestingly, Col5a1 and Col3a1 have been recognized as regulators of integrin 
organization (Zoppi et al., 2004), indicating a possible signaling pathway within the extracellular matrix. 
Additionally, Srebrow and colleagues showed that collagen type IV and laminin can inhibit extra domain I 
inclusion within fibronectin (Srebrow et al., 2002). BMP-2 and TGF-beta 1 are able to bind to Col2a1 (Zhu et al., 
1999), and these two molecules, also display different effects in the promotion of the expression of collagen 
type II isoforms; BMP-2 promotes the expression of Col2a1b, while TGF-beta 1 favors the expression of 
Col2a1a (Valcourt et al., 2003).  
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 Possible role of microRNAs.  The transcription level regulation of minor fibrillar collagen genes is not 
thoroughly understood, and it is possible that new nuclear factors will be discovered in the future. However, 
there may be another mechanism regulating the alternative splicing of type XI collagen genes. Although current 
understanding of the role of microRNA (miRNA) in regulating alternative splicing is limited, evidence supports 
the regulation of components of the spliceosome (Makeyev and Maniatis, 2008).  It is possible that miRNAs 
regulate the expression of Col11a1, given the fact that miRNAs have a profound effect on vertebrate 
development post-transcriptionally (Makeyev and Maniatis, 2008). To predict possible miRNAs involved in the 
regulation of the expression of minor fibrillar collagens, we used Pictar (Krek et al., 2005) and TargetScan 
(Grimson et al., 2007) to analyze the 3’ UTR of all human collagen type V and XI genes. Although the collagen 
genes analyzed were predicted to be the targets of many different miRNAs, all are potential targets of the miR-
29a/b/c family except Col11a2, suggesting a possible co-regulation mechanism. MiR-29s have been showed to 
participate in many different pathways, including methyltransferase 3A/3B in cancer (Fabbri et al., 2007), 
BACE/beta-secretase in Alzheimer’s disease, p85alpha, and CDC42 in promoting apoptosis (Park et al., 2009). 
Noteworthy, previous studies by others have shown that miR-29 family members regulate the expression of a 
broad range of collagen genes (Sengupta et al., 2008). In addition to the minor fibrillar collagen genes, Col1a1, 
Col2a1, and Col3a1 also possess the consensus sites for the miR-29a/b/c family. The targets of miRNAs can 
alter the expression of downstream genes themselves if they are upstream signaling molecules, transcription 
factors (Makeyev and Maniatis, 2008), or trans-acting elements. Kato and colleagues found that miR-192 
represses the expression of the E-box repressor, resulting in an enhanced expression level of Col1a2 in kidney 
cells (Kato et al., 2007). This phenomenon potentially increases the complexity with which miRNAs may exert 
their effect on the target genes. It is also possible that miRNAs regulate the enzymes that degrade collagens in 
the extracellular matrix. Therefore, direct prediction through 3’ UTR of a given gene will not tell the entire story.  
 
Conclusion 
 
The spatiotemporal expression patterns of minor fibrillar collagens are not well documented in early embryonic 
developmental stages. Demonstrated by the homozygous mutants of Col11a1 and Col5a1, embryonic lethality 
indicates that minor fibrillar collagens are crucial during development. Although their roles in fibrillogenesis 
have been emphasized, other potential functional aspects are not as well understood, and require a concentrated 
research effort.  Noncollagenous domains such as the variable regions may also contribute to the function of 
minor fibrillar collagens. Alternative splicing determination of extra heparan sulfate binding sites within the 
variable region of Col11a1 provides evidence for their specialization among the splice-forms with respect to 
unique functions. Detailed expressional and more extensive functional studies are needed. Although the alpha 
chains of collagen type V and XI do not show high sequence identity within the variable region, the distribution 
of charged side chains, such as tyrosine and lysine, is conserved. This indicates that Col5a3 may harbor similar 
binding sites for heparan sulfate as demonstrated for Col11a1. The prediction of sulfation modification to 
tyrosines also suggests that Col11a1 and Col5a1 may undergo similar post-transcriptional modification.  
Different isoforms resulting from alternative splicing are differentially expressed during development for 
Col11a1, Col11a2, and Col1a3 (Col2a1). Although this is a strong indication that specific isoforms play novel 
functional roles, direct evidence is still lacking. The transcriptional regulation is similar for all minor fibrillar 
collagen genes; however, the alternative splicing tends to be more diverse. Although the regulation of Col2a1 
has been described extensively, less information is available for Col11a1 and Col11a2. It is tempting to 
speculate that other factors contribute to the expressional regulation of minor fibrillar collagens, such as the mir-
29 family, which has been suggested as a master regulator for collagen genes. This suggestion is supported by 
the findings that the mir-29 microRNA family has diverse roles in regulating cell survival related genes, in lung 
cancer, breast cancer and Alzheimer’s disease. Col11a1 has also been related to certain cancer types. Recently a 
relation between alternative splicing and intrinsic disorder has been described (Romero et al., 2006). The 
increased flexibility provided by intrinsic disorder may mechanistically connect the functions of different 
splicing-forms to their function. However, whether the predicted intrinsic disorder in the variable regions of 
minor fibrillar collagens does contribute to their functions is not clear at present, and must await further study.  
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 Figure legends. 
 
Figure 1. Conservation in the variable regions of Col5a1, Col5a3, Col11a1 and Col11a2 among human, 
chimpanzee, mouse, rat, chicken and zebrafish.  Alignment of peptides encoded by exon 6, 7 and 8 of Col5a1, 
Col5a3, Col11a1 and Col11a2, were carried out and are displayed as LOGOS to highlight the conserved 
sequences.  Negatively charged glutamic acid and aspartic acid (D and E) are shown in red, glycine, tyrosine, 
serine, threonine (G, Y, S, and T) are shown in green), proline, alanine, leucine, methionine, valine, 
phenylalanine, isoleucine (P, A, L, M, V, F, and I) are shown in black, glutamine and asparagines (Q and N) are 
shown in purple, lysine and arginines (K and R) are shown in blue.  Relative height of single letter abbreviation 
in each sequence position indicates the relative frequency of amino acid used among the six species compared.  
Exon-intron boundaries in zebrafish sequence are not well defined based on current annotation of Col5a3 
therefore, sequence encoded by Col5a3 variable region was compared in total.  Exon assignments were made 
according to the human sequences, and sequences from other species are in agreement with the human in most 
cases. However, for Col5a1, exon4, 5, 6 were used from chicken for the alignment of Col5a1e6, Col5a1e7 and 
Col5a1e8, respectively; whereas for Chimp, exon 7, 8 and 9 were used in the same alignment.  Alignment is 
shown in Supplemental Figure 1. Accession numbers are given in the Supplemental Table 1. 
 
Figure 2.  Model of heterotypic thin collagen fibril. The minor fibrillar collagen type XI (blue) is shown in the 
core of the fibril with the major fibrillar collagen type II (orange) making up the bulk of the fibril.  The fibril 
associated collagen with interrupted triple helix (FACIT) collagen type IX (green) is shown associated with the 
surface of the collagen fibril.  The structure of Collagen type II was created using the PyMOL Molecular 
Graphics System, Version 1.3, (Schrödinger, LLC).  The structure of ColXI was created as a homology model 
built from the ColIX (2UUR) structure template. (McDougal et al., 2011). 
 
Figure 3. Prediction of sulfation modification and intrinsic disorder within the variable region of human minor 
fibrillar collagens.  Prediction of sulfation modification was carried out using SulfoSite and intrinsic disorder of 
the variable region was identified by VLXT for the human minor fibrillar collagens. A. Col5a1, B. Col5a3, C. 
Col11a1, and D. Col11a2. Red squared tyrosines (Y) are those predicted to be sulfation modification sites. 
Underlined letters represent predicted intrinsic disorder; Red arrows point to the exon boundaries in the variable 
region for each collagen.  
 
Figure 4. Potential interactions between collagen fibril surface domains and cell surface receptors. Examples of 
cell surface receptors that interact with extracellular matrix collagen fibrils include DDR2 (red) and integrins 
(yellow). TGFβR (cyan) is shown as an example of growth factor receptors that may be influenced by 
interaction between growth factors and the extracellular matrix molecules, resulting in either the inhibition of 
cell signaling events via sequestration, or alternatively, the facilitated delivery of the signaling molecule to its 
destination on the cell surface receptor.  Abbreviations: TGFβR, transforming growth factor beta receptor; 
DDR2, discoidin domain receptor 2. Structures with accession numbers are as follows: ColIX (2UUR), TGFR 
(1B6C, 2L5S), DDR2 (2WUH, 2SRC), integrin (1JV2, 2K9J), and the lipid bilayer was obtained from 
http://www.umass.edu/microbio/rasmol/ bilayers.htm. (Heller et al., 1993).  The structure of ColII was created 
using The PyMOL Molecular Graphics System, Version 1.3, Schrödinger, LLC.  The structure of ColXI was 
created as a homology model built from the ColIX (2UUR) structure template. (McDougal et al., 2011). 
 
Supplemental Figure 1. Conservation in the variable regions of Col5a1, Col5a3, Col11a1 and Col11a2 among 
human, chimpanzee, mouse, rat, chicken and zebrafish. A, C. Alignment of peptides encoded by exon 6, 7 and 8 
of Col5a1and Col11a2, respectively; B. Alignment of peptides encoded by exon 6, 7 and 8 of Col5a3; Red 
arrows point to the boundaries of exon 6-7 and exon 7-8, respectively. Exon-intron boundaries in zebrafish 
sequence are not well defined based on current annotation of Col5a3; D. Alignment of peptides encoded by 
exon 6A, 6B, 7 and 8 of Col11a1. E6, encoded by exon6; E7, encoded by exon7; E8, encoded by exon8. Exon 
assignments are made according to the human sequences, sequences from other species are in agreement with 
them. However, for Col5a1, exon4, 5, 6 were used from chicken for the alignment of Col5a1_E6, Col5a1_E7 
and Col5a1_E8, respectively; whereas for Chimp, exon 7, 8 and 9 were used in the same alignment (A). 
Accession numbers are given in the Supplemental Table 1.  The underlined segments represent the conserved 
region among species. Colored letters in blue represent the conserved residue among species. 
 
Supplemental Figure 2.  Exon-intron boundaries in the variable region of Col11a1, Col11a2, Col5a1, and 
Col5a3.  Logos upstream of the exon-intron boundary represent the 5’-donor sites, while logos downstream 
represent the 3’-acceptor sites.  Each boundary is shown as 20 nucleotides, comprising 10 nucleotides from the 
exon and 10 nucleotides from the intron.  Interestingly, the acceptor sites of intron 6A-6B and intron 6-7 in 
Col11a1 and Col11a2, respectively, exhibit a possible hairpin structure pattern.   
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 Tables. 
Table 1. Summary of the spatiotemporal expression patterns of the minor fibrillar collagens. 
 
Table 2. Prediction of isoelectric point for each peptide in the variable regions of minor 
fibrillar collagens 
Fragments Sequence Average pI 
Col5a1 p6 YTEGDGEGETYYYEYPYYEDPEDLGKEPTPSKKPVEAAKETTEVPE 4.08 
p7 ELTPTPTEAAPMPETSEGAGKEEDVGIGDYDYVPSEDYYTPSPYDDLTYGEGE
ENPDQPTDPGAGAEIPTSTADTSNSSN 
3.20 
p8 PAPPPGEGADDLEGEFTEETIRNLDENYYDPYYDPTSSPSEIGPGMPANQDTIY
EG 
3.36 
Col5a3 p6 APQGEPETPRPRRKGKGKGRKKGRGRKGKGRKKNKEIWTSSPPPDSAENQ 11.39 
p7 TSTDIPKTETPAPNLPPTPTPLVVTSTVTTGLNATILE 4.43 
p8 RSLDPDSGTELGTLETKAAREDEEGDDSTMGPDFRAAEYPSRTQFQIFP 4.13 
Col11a1 p6A YAPEDIIEYDYEYGEAEYKEAESVTEGPTVTEETIAQTE 3.61 
p6B KKKSNFKKKMRTVATKSKEKSKKFTPPKSEKFSSKKKKSYQASAKAKLGVK 10.77 
p7 ANIVDDFQEYNYGTMESYQTEAPRHVSGTNE 4.24 
p8 PNPVEEIFTEEYLTGEDYDSQRKNSEDTLYENKEIDGRDSDLLVDGDLGEYDF
YEYKEYEDKPTSPPNEEFGPGVPAETDITETS 
3.75 
Col11a2 p6 PTESLYYDYEPPYYDVMTTGTTPDYQ 3.33 
p7 PTPGEEEEILESSLLPPLEE 3.63 
p8 EQTDLQVPPTADRFQAEEYGEGGTDPPEGPYDYTYGYGDDYREETELGPALS
AETAHSGA 
3.73 
 
Gene 7.5 8.5 – 9.5 10.5 11.5 12.5 – 13.5 14.5 – 15.5 16.5 – 18.5 
Col5a1 Not 
detectable 
Dorsal 
aorta; 
heart 
Nerves; blood vessels; 
neuroepithelium; 
Trabeculated wall of 
the common 
ventricular chamber of 
the heart; dorsal aorta 
wall; mesonephrotic 
tubules; branchial 
arches; mesenchyme 
Developing 
mesenchyme 
(cephalic 
mesenchyme 
and the trunk 
region 
around 
somites) 
Vertebral 
column; 
craniofacial 
tissues 
Perichondriu
m; corneal 
stroma; 
tendon 
Developing skin; 
odontoldasts; vertebrae; 
 
Vertebrae; mandibular arch 
     Intestinal mesenchyme 
Col5a2  Peritoneal 
membranes; 
intestinal 
mesenchyme 
craniofacial 
mesenchyme 
Primary ossified regions; perichondrium; 
joints; tendon; diaphragm; peritoneal 
membrane; atriioventricular valve; 
mandibular arch; tongue; optic nerve 
region; otic capsule; calvarial mesenchyme 
Col5a3  
Mammary glands; placenta; uterus; heart; lung; brain  
Superficial fascia; 
epimysia; lining on 
the developing 
muscles; epineureum 
of some nerves 
 
Col11a1  Notochord; 
+sclerotome 
of the 
somites 
Sclerotome-
derived 
condensations; 
notochord 
All cartilaginous 
tissues 
Mesothelial layer of the cornea; 
condensation of perioptic mesenchyme 
within sclera; calvarium; limbs; tendons 
Nasal; 
mesenchymal 
condensation; 
limbs 
Col11a2   +Notochord 
 
sclerotome 
of the 
somites 
Sclerotome-
derived 
condensations; 
notochord 
Nasal; 
mesenchymal 
condensation; 
limbs (isoforms 
w/o exon6-8) 
All cartilaginous 
tissues (isoforms w/o 
exon6-8) 
calvarium; limbs (isoforms w/ exon6-8) 
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 Table 3. Summary of the transcriptional factors for each minor fibrillar collagen gene 
Gene Proximal promoter Transcription factor(s) identified 
Col11a1 TATA box lack, GC rich AP2, SP1, FP9C, CBF/NF-Y 
Col11a2 TATA box lack, GC rich SP1, EWS/ERG, NT2 
Col5a1 TATA box lack, CCAAT 
box lack, GC rich 
SP1, CBF, SP1-related protein (SP3?) 
Col5a2 Similar to Col11a1, 
CCAAT box lack, 
TATA-like element 
FP-A, FP-B, PBX1/2, PREP1, HOXB1 
Col5a3 TATA box lack, GC rich CBF/NF-Y 
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 Supplementary Table 1. Sequences of minor fibrillar collagen analyzed 
Collagen gene Species Exon Accession # 
Col5a1 
Human 
6 ENSE00001096546 
7 ENSE00001096535 
8 ENSE00001096560    
Chimpanzee 
7 ENSPTRE00000290983   
8 ENSPTRE00000212907 
9 ENSPTRE00000212861 
Mouse 
6 ENSMUSE00000228180 
7 ENSMUSE00000228173   
8 ENSMUSE00000228167 
Rat 
6 ENSRNOE00000082211 
7 ENSRNOE00000082306 
8 ENSRNOE00000082405 
Chicken 
4 ENSGALE00000257225 
5 ENSGALE00000025348 
6 ENSGALE00000025350 
Zebrafish
*
 
6  
7  
8  
Col5a3 
Human 
6 ENSE00000414048 
7 ENSE00001261185 
8 ENSE00001261182    
Chimpanzee 
6 ENSPTRE00000104021 
7 ENSPTRE00000104036 
8 ENSPTRE00000245728 
Mouse 
6 ENSMUSE00000217149 
7 ENSMUSE00000217141 
8 ENSMUSE00000217191 
Rat 
6 ENSRNOE00000333603 
7 ENSRNOE00000310165 
8 ENSRNOE00000283884 
Zebrafish
*
 
6  
7  
8  
Col11a1 
Human 
6A ENSE00001028998 
6B ENSE00001166589 
7 ENSE00001029018 
8 ENSE00001029017 
Chimpanzee 
6A ENSPTRE00000010446 
6B ENSPTRE00000010408 
7 ENSPTRE00000223096 
8 ENSPTRE00000223097 
Mouse 
6A ENSMUSE00000326321 
6B ENSMUSE00000636373 
7 ENSMUSE00000636372 
8 ENSMUSE00000718532 
Rat 
6A ENSRNOE00000245416 
6B ENSRNOE00000245404 
7 ENSRNOE00000245393 
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 8 ENSRNOE00000245385 
Chicken 
6A ENSGALE00000054888 
6B ENSGALE00000054946 
7 ENSGALE00000054951 
8 ENSGALE00000054932 
Zebrafish
*
 
6A  
6B  
7  
8  
Col11a2 
Human 
6 ENSE00001464632 
7 ENSE00001464630 
8 ENSE00001464627 
Chimpanzee 
6 ENSPTRE00000263130 
7 ENSPTRE00000263133 
8 ENSPTRE00000334359 
9 ENSPTRE00000263131 
Mouse 
6 ENSMUSE00000140957 
7 ENSMUSE00000141005 
8 ENSMUSE00000140983 
Rat 
6 ENSRNOE00000003154 
7 ENSRNOE00000003155 
8 ENSRNOE00000003156 
Zebrafish
*
 
6  
7  
8  
*Zebrafish sequences were based on our lab’s sequencing results from RT-PCR experiments. 
Primers were designed based on the highly similar hit in zebrafish corresponding to each of 
the human minor fibrillar collagen genes (Col5a1, Col5a3, Col11a1 and Col11a2). The 
zebrafish used in our lab are AB background. Exon assignments were based on the alignment 
of our sequencing results to the genomic sequence of corresponding gene in zebrafish from 
NCBI. Alignments were performed by Blast and ClustalW. 
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 Supplementary Table 2. Exon-intron junction sequences in variable region of minor fibrillar 
collagens. 
Collagen 
gene 
Species 
Donor/Acceptor 
site
*
 
Sequence 
Col5a1 
Human 
e5i5 AGATGAATATgtgagttaac 
i5e6 tcgctttcagTACACGGAAG 
e6i6 GGTCCCCGAGgtctgggctg 
i6e7 tggctcccagGAGCTGACCC 
e7i7 CTCCTCCAATgtaatttctt 
i7e8 ccctctgcagCCAGCTCCGC 
e8i8 CTATGAAGGGgtgagagggt 
i8e9 tcacccccagATTGGAGGAC 
Chimpanzee 
e5i5 AGATGAATATgtgagttaac 
i5e6 tcgctttcagTATACGGAAG 
e6i6 GGTCTCCAAGgtctgggctg 
i6e7 tggctcccagGAGCTGACCC 
e7i7 CTCCTCCAATgtaatttctt 
i7e8 ccctctgcagCCAGCTCCGC 
e8i8 CTATGAAGGGgtgagagggt 
i8e9 tcacccccagATTGGAGGAC 
Mouse 
e5i5 GGATGAATATgtgagtcatc 
i5e6 ttgacctcagTACCCAGAAG 
e6i6 GGTTCCTGAGgtctgatctg 
i6e7 ctgcccacagGAGCAGACCC 
e7i7 CACCTCCAATgtaattgcct 
i7e8 taatctgcagCCAGCTCCAG 
e8i8 CTTTGAGGGGgtaagagact 
i8e9 atctttccagATTGGAGGAC 
Rat 
e5i5 AGATGAATATgtgagtcatc 
i5e6 ttgacttcagTACCCAGAAG 
e6i6 GGTTCCTGAGgtctgatctg 
i6e7 ctgcccacagGAGCAGACCC 
e7i7 TTCCTCCAATgtaattgccc 
i7e8 taatctgcagCCGGCTCCAT 
e8i8 CTATGAAGGGgtaagagacg 
i8e9 ccaaactcagATTGGAGGAC 
Chicken 
e5i5 CAGATGGCAAgtaagtgaaa 
i5e6 gctcttgcagGTGGCACAGG 
e6i6 AGTCTTCGAGgtaagtcacg 
i6e7 ctccccgcagGGCGACATCC 
e7i7 GGATGAATACgtgagtagga 
i7e8 ctctctgcagTATACCGATG 
e8i8 AACCAAGCAGgtacccacgt 
i8e9 tccacaccagGACTATCCTT 
Col5a3 Human 
e5i5 AGCCACAGTGgtgagtgagg 
i5e6 cttctcccagGCTCCCCAGG 
e6i6 AGAGAACCAGgtaagggccc 
i6e7 cctgctccagACCTCCACTG 
e7i7 GATCCTAGAGgttggatggg 
i7e8 acgttctcagAGGAGCTTGG 
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 e8i8 GATCTTTCCTgtgagtttct 
i8e9 cccaccccagGGTGCTGGAG 
Chimpanzee 
e5i5 AGCCACAGTGgtgagtgagg 
i5e6 cttctcccagGCTCCCCAGG 
e6i6 AGAGAACCAGgtaagggccc 
i6e7 cctgctccagACCTCCACTG 
e7i7 GATCCTAGAGgttggatggg 
i7e8 acgttctcagGGGAGCTTGG 
e8i8 GATCTTTCCTgtgagtttct 
i8e9 cccaccccagGGTGCTGGAG 
Mouse 
e5i5 AACCACAGGGgtgagtgggg 
i5e6 ctttcctcagGCCCCCAAAG 
e6i6 TGAGAACCAGgtaagaaccc 
i6e7 tctgctgcagACCTCCCTCC 
e7i7 AGTCTCGCAGgttggtggga 
i7e8 tcctccacagGGGTTGGACT 
e8i8 GATCTTTCCTgtgagtctac 
i8e9 ctgtccctagGGTGCTGGAG 
Rat 
e5i5 AACCACAGGGgtgagtaggg 
i5e6 ctttcctcagGTCACTAAAG 
e6i6 TGAGAACCAGgtaagaacct 
i6e7 tctgctgcagACCTCCCTCC 
e7i7 AGTTTTGCAGgttggcagga 
i7e8 tcctctgcagGGGTTGGACT 
e8i8 GATCTTTCCTgtgagtctgg 
i8e9 ctgttcccagGGTGCTGGAG 
Col11a1 
Human 
e5i5 GATAGATGAGgtgaggagca 
i5e6A tgcaatgtagTATGCACCAG 
e6Ai6A ACAGACGGAGgtaaaaacaa 
i6Ae6B cattttacagAAAAAGAAAT 
e6Bi6B AGGGGTAAAGgtagcgaaga 
i6Be7 ttaccattagGCAAACATCG 
e7i7 GACAAATGAGgtaatacgta 
i7e8 aaattaatagCCAAATCCAG 
e8i8 AGAAACAAGCgtaagttgat 
i8e9 cattcaacagATAAATGGCC 
Chimpanzee 
e5i5 CATTGATGAGgtgaggagga 
i5e6A tgcaacatagTATGCACCTG 
e6Ai6A ACAAACAGAGgtaaaaccaa 
i6Ae6B cattttacagAAAAAGAAAT 
e6Bi6B AGGGGTCCAGgtagcgagaa 
i6Be7 ttatcatcagGCAAATATTG 
e7i7 ATCGAATGAGgtaatccagc 
i7e8 aaatgaatagCCAAATCCAG 
e8i8 AGAAACAAGCgtaagtcagc 
i8e9 cgctcaatagATAAATGGAC 
Mouse 
e5i5 CATAGATGAGgtaagatgca 
i5e6A tgcaacgaagTATGCACCTG 
e6Ai6A ACAAACTGAGgtaaaaccaa 
i6Ae6B cgttttacagAAAAAGAAAT 
20
 e6Bi6B AGGGGTCCAGgtagcaagaa 
i6Be7 ttatcatcagGCAAATATTG 
e7i7 ATCAAATGAGgtaatccagc 
i7e8 aaatgaatagCCAAATCCAG 
e8i8 AGAAACAAGCgtaagtcagc 
i8e9 tgctcaatagATCAATGGCC 
Rat 
e5i5 GATAGATGAGgtgaggagca 
i5e6A tgcaatgtagTATGCACCAG 
e6Ai6A ACAGACGGAGgtaaaaacaa 
i6Ae6B cattttacagAAAAAGAAAT 
e6Bi6B AGGGGTAAAGgtagcaaaga 
i6Be7 ttaccattagGCAAATATCG 
e7i7 GACAAATGAGgtaatacgta 
i7e8 aaattaatagCCAAATCCAG 
e8i8 AGAAACAAGCgtaagttgat 
i8e9 cattcaacagATAAATGGCC 
Chicken 
e5i5 AGTTGATGAGgtgagtaatc 
i5e6A tgctgtgtagTACACACCAG 
e6Ai6A ACAAACAGAGgtaacagaat 
i6Ae6B acatttgcagAAAAGGAAAG 
e6Bi6B CAAACTAGGGgtaaaagtag 
i6Be7 ttaatattag GCAAACATTG  
e7i7 AGCCAATGAG gtaatgagaa 
i7e8 atatgaatag CAAAAACCTG  
e8i8 AGAAACAAGC gtaagttgat 
i8e9 tactggtcag GTAACACAAC 
Col11a2 
Human 
e5i5 CCAGAGCCAGgtgagggagc 
i5e6 ccaatcccagCCCACTGAGT 
e6i6 TGATTATCAGgtaaactcaa 
i6e7 ttggggtcagGACCCCACCC 
e7i7 CCTTGAGGAGgtaactctat 
i7e8 ccctgggaagGAGCAGACAG 
e8i8 CTCAGGAGCCgtaagtgaaa 
i8e9 tctccttcagGCTGCCCATG 
Chimpanzee 
e5i5 CCAGAGCCAGgtgagggagc 
i5e6 ccaatcccagCCCACTGAGT 
e6i6 TGATTATCAGgtaaactcaa 
i6e7 ttggggtcagGACCCCACCC 
e7i7 CCTTGAGGAGgtaactctat 
i7e8 ccctgggaagGAGCAGACAG 
e8i8 CTCAGGAGCCgtaagtgaaa 
i8e9 tctccttcagGCTGCCCATG 
Mouse 
e5i5 CCAGAAGCAGgtgagggggt 
i5e6 ctgctcccagCCCACTGAGT 
e6i6 TGATTATCAGgtaacctcga 
i6e7 ttggggctagTACCCCACCC 
e7i7 CCTTGAAGAGgtaacttcat 
i7e8 ccttgggaagGAGCAGACAG 
e8i8 CTCAGGAGCCgtaagtggaa 
i8e9 tctccctcagGTTGCCCACG 
21
 Rat 
e5i5 CCAGCAGCAGgtgagggagt 
i5e6 ctgctcccagCCCACTGAAT 
e6i6 TGATTACCAGgtaacctcca 
i6e7 ttggggctagTACCCCACCC 
e7i7 TCTTGAAGAGgtaacttcac 
i7e8 ccttgggaagGAGCAGACAG 
e8i8 CACAGGAGCCgtaagtggaa 
i8e9 tctccctcagGTTGCCCACG 
*Donor/acceptor sites are expressed in eXiY/iYeX. X represents the exon number, and Y represents the intron 
downstream of the exon X for the donor site; whereas for the acceptor site, X represents the exon number, but Y 
represents the intron upstream of the exon X.  
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